A recent study showed that CD44 isoform switching from expressing CD44v to CD44s was essential for epithelial to mesenchymal transition (EMT) during breast cancer progression [60]; whereas, CD44 variants are reported to be associated with metastatic lesions and with a poor prognosis [30, 61]. This evidence concerns the gene CD44 and breast cancer.